July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Effect of NOD ligand stimulation on human retinal pigmented epithelial (ARPE-19) cells N-acetylmuramyl-L-alanine amidase, glutathione and gamma-glutamyltranspeptidase activity
Author Affiliations & Notes
  • Jason So
    Ophthalmology, LSUHSC Shreveport, Shreveport, Louisiana, United States
  • Laura Perilloux
    Ophthalmology, LSUHSC Shreveport, Shreveport, Louisiana, United States
  • Arthur Scott Kavanaugh
    Ophthalmology, LSUHSC Shreveport, Shreveport, Louisiana, United States
  • William A. Byrd
    Ophthalmology, LSUHSC Shreveport, Shreveport, Louisiana, United States
  • Marlyn P Langford
    Ophthalmology, LSUHSC Shreveport, Shreveport, Louisiana, United States
  • Footnotes
    Commercial Relationships   Jason So, None; Laura Perilloux, None; Arthur Kavanaugh, None; William Byrd, None; Marlyn Langford, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1686. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jason So, Laura Perilloux, Arthur Scott Kavanaugh, William A. Byrd, Marlyn P Langford; Effect of NOD ligand stimulation on human retinal pigmented epithelial (ARPE-19) cells N-acetylmuramyl-L-alanine amidase, glutathione and gamma-glutamyltranspeptidase activity. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1686.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinopathy of unknown etiology involving central serous retinal detachment (CSRD) can be associated with occult bacterial infection. A putative role for bacterial peptidoglycan in development of CSRD has not been elucidated. We investigate the presence, activity, and induction of N-acetylmuramyl-L-alanine amidase [NAMAA; also known as peptidoglycan recognition protein (PGRP-2)] as well as NOD ligand-induced stress in human retinal pigmented epithelium (HRPE) cells as an in vitro model of bacteria-induced retinopathy.

Methods : HRPE NAMAA activity was measured densitometrically using cleavage of FITC-labeled MDP by HRPE cell lysates followed by agarose gel electrophoresis. The effects of NOD1, NOD2, and NOD1/2 ligand stimulation on the RPE amidase activity, as well as on other biochemical markers [caspase-3, gamma-glutamyl transpeptidase (GGT), and glutathione (GSH)] were tested. Specific inhibition of the NAMAA activity was determined by anti-PGRP specific antibodies and was visualize in ethanol fixed HRPE by immunofluorescent antibody labelling.

Results : The agarose gel method to detect NAMAA cleaved FITC-MDP (NOD2 ligand) was sensitive down to 5 ng. HRPE cell lysates contained enzymatic activity that cleaves FITC tagged MDP in a dose and time-dependent manner. Multiple PGRP (PGN receptor proteins) were detected in HRPE cells by immunofluorescent antibody (IFA). Antibodies to PGRP 1 and 2 were shown to inhibit the HRPE’s NAMAA activity by inhibiting its cleavage of FITC-MDP. NOD1/2 ligand stimulation of RPE cells did not stimulate increased NAMAA or caspase activity, but NOD ligand incubation for 24-72 h decreased glutathione (GSH) and increased gamma-glutamyltranspeptidase (GGT) activity.

Conclusions : The results suggest that HRPE NAMAA activity may contribute to retinal innate immunity; potentially acting against the effects of bacterial infection. That is, the NAMAA may cleave L-alanyl containing peptidoglycans and inhibit pro-inflammatory activity. Concomitantly, the results suggest that NOD ligand stimulation of HRPE cells leads to oxidative stress suggested by loss of anti-oxidant potential (reduced GSH) and increased GGT activity (GSH recapture).

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×